Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum glial cell line-derived neurotrophic factor: a potential biomarker for white matter alteration in Parkinson’s disease with mild cognitive impairment

24 Oct 2024

Abstract excerpt

Objective: Mild cognitive impairment (MCI) is a common non-motor manifestation of Parkinson's disease, commonly referred to as PD-MCI. However, there is a lack of comprehensive data regarding the role of glial cell line-derived neurotrophic factor (GDNF) and cerebral white matter damage in the pathogenesis of PD-MCI. The objective of this study is to investigate the association between alterations in GDNF levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Neuroimaging Techniques and Applications
Share to Nerve injury and regeneration
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39513043
DOI: 10.3389/fnins.2024.1370787

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum glial cell line-derived neurotrophic factor: a potential biomarker for white matter alteration in Parkinson’s disease with mild cognitive impairmentPMID 39513043Read ↗

Characterizing the distinct neuroanatomical phenotypes, cognitive profiles, and transcriptomic signatures of brain structural subtypes in Parkinson's disease with mild cognitive impairment.Semantic proximity Read ↗

Cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's DiseaseSemantic proximity Read ↗

Executive function network’s white matter alterations relate to Parkinson’s disease motor phenotypeSemantic proximity Read ↗

Mild Behavioral Impairment in Parkinson's Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects.Semantic proximity Read ↗

Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.Semantic proximity Read ↗

White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.Semantic proximity Read ↗

Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.Semantic proximity Read ↗

White Matter Hyperintensities, Grey Matter Atrophy, and Cognitive Decline in Neurodegenerative DiseasesSemantic proximity Read ↗

What can biomarkers tell us about cognition in Parkinson's disease?Semantic proximity Read ↗

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony-Stimulating Factor-1 Receptor-Related DisordersSemantic proximity Read ↗

Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson's disease patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.